Increased frequency and clinical significance of myeloid-derived suppressor cells in human colorectal carcinoma

doi:10.3748/wjg.v18.i25.3303

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 25

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2809)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

378

HTML

2095

Figures (1-2)

188

Tables (1-1)

148

Sum=2809

Jul 7, 2012 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Jul 7, 2012; 18(25): 3303-3309
Published online Jul 7, 2012. doi: 10.3748/wjg.v18.i25.3303

Full Size Figure Download Figure

Figure 2 Phenotypic analyses of CD33⁺HLA-DR^- myeloid-derived suppressor cells in colorectal carcinoma patients and healthy donors. A: Cell surface markers of peripheral blood myeloid-derived suppressor cells (MDSCs), obtained by gating on the CD33⁺HLA-DR^- subset, were detected in colorectal carcinoma (CRC) patients; B: Percentages of cells positive for various markers on the CD33⁺HLA-DR^- subset in healthy donors (HD) and CRC patients (^aP < 0.05).

Citation: Sun HL, Zhou X, Xue YF, Wang K, Shen YF, Mao JJ, Guo HF, Miao ZN. Increased frequency and clinical significance of myeloid-derived suppressor cells in human colorectal carcinoma. World J Gastroenterol 2012; 18(25): 3303-3309
URL: https://www.wjgnet.com/1007-9327/full/v18/i25/3303.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i25.3303